P2RY1

Purinergic Receptor P2Y1

Gene Information Card

Symbol P2RY1
Full Name Purinergic Receptor P2Y1
Gene Type protein-coding
Chromosomal Location 3q25.2
NCBI Gene ID 5028 ncbi.nlm.nih.gov/gene/5028
Ensembl ID ENSG00000169896
UniProt ID P47900
OMIM ID 601167
HGNC ID 8539
Aliases P2Y1, P2Y1R, P2RY1

Description

The P2RY1 gene encodes the P2Y1 receptor, a G protein-coupled receptor (GPCR) activated by extracellular adenosine diphosphate (ADP). It plays a critical role in platelet aggregation, vascular tone regulation, and inflammatory responses. Mutations in P2RY1 are associated with bleeding disorders and altered thrombotic risk.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Bleeding disorder, platelet-type, 8 (BDPLT8) Loss-of-function mutations impair ADP-induced platelet aggregation OMIM #601167; ClinVar
Thrombosis susceptibility Gain-of-function variants enhance platelet reactivity ClinVar; literature
Coronary artery disease Polymorphisms linked to altered platelet activation NCBI Gene; GWAS

Expression Profile

Tissue Expression
Tissue nTPM level
Whole blood 12.5 Medium
Spleen 8.3 Low
Lung 6.1 Low
Brain 4.7 Low
Heart 3.9 Low
Cell Line Expression
Cell Line nTPM Notes
Megakaryocytes 45.2 High expression
Platelets 30.1 High expression
HEK293 2.3 Low expression
HUVEC 5.8 Medium expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.893C>T (p.Thr298Met) Missense 0.02% (gnomAD) Reduced ADP binding; loss of function
c.136G>A (p.Gly46Arg) Missense 0.01% (gnomAD) Impaired receptor activation; loss of function
c.100C>T (p.Arg34Cys) Missense 0.005% (gnomAD) Decreased surface expression; loss of function
Mutation functional classification

Loss of Function (LOF)

Missense variants (e.g., p.Thr298Met, p.Gly46Arg) reduce ADP binding or receptor activation, leading to impaired platelet aggregation and bleeding tendency.

Gain of Function (GOF)

Rare variants (e.g., p.Val241Ile) reported to increase receptor sensitivity to ADP, associated with enhanced platelet aggregation and thrombotic risk.

Dominant Negative (DN)

No dominant-negative mutations currently documented in P2RY1.

Pathways

ADP signaling through P2Y purinoceptor 1 (Reactome: R-HSA-418594)
Platelet activation
signaling and aggregation (Reactome: R-HSA-76002)
G alpha (q) signalling events (Reactome: R-HSA-416476)

Protein Summary

The P2Y1 receptor is a 373-amino acid GPCR with seven transmembrane domains. It is predominantly expressed on platelets and megakaryocytes, where it mediates ADP-induced platelet shape change and aggregation via Gq/11 activation, leading to phospholipase C beta activation and intracellular calcium mobilization. The receptor also contributes to vascular endothelial function and inflammation.

Related Products

Product name Cat.No. Species Gene ID
P2RY1 Knockout HEK293 Cell Line EDJ-KQ1287 Human 5028 Details Get a Quote
P2RY14 Knockout HEK293 Cell Line EDJ-KQ6825 Human 9934 Details Get a Quote
P2RY10 Knockout HEK293 Cell Line EDJ-KQ8776 Human 27334 Details Get a Quote
P2RY1 Knockout HCT 116 Cell Line EDJ-KQ20687 Human 5028 Details Get a Quote
P2RY11 Knockout HEK293 Cell Line EDJ-KQ50498 Human 5032 Details Get a Quote
P2RY13 Knockout HEK293 Cell Line EDJ-KQ51354 Human 53829 Details Get a Quote
P2RY12 Knockout HEK293 Cell Line EDJ-KQ51631 Human 64805 Details Get a Quote
PPAN-P2RY11 Knockout HEK293 Cell Line EDJ-KQ52396 Human 692312 Details Get a Quote
P2RY1 Knockout HeLa Cell Line EDJ-KQ54069 Human 5028 Details Get a Quote
P2RY11 Knockout HeLa Cell Line EDJ-KQ54071 Human 5032 Details Get a Quote
P2RY14 Knockout HeLa Cell Line EDJ-KQ55279 Human 9934 Details Get a Quote
P2RY10 Knockout HeLa Cell Line EDJ-KQ56061 Human 27334 Details Get a Quote
P2RY13 Knockout HeLa Cell Line EDJ-KQ56381 Human 53829 Details Get a Quote
P2RY12 Knockout HeLa Cell Line EDJ-KQ57083 Human 64805 Details Get a Quote
PPAN-P2RY11 Knockout HeLa Cell Line EDJ-KQ60674 Human 692312 Details Get a Quote
Displaying Records 1 To 15 Of 28 Records
Contact Us
*
*
*
*
How did you hear about us: